Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors
Clinical trial NCT00027677 · COMPLETED
Trial details
- NCT number
- NCT00027677
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-08-01
- Primary completion
- 2004-02-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.